Sunitinib is an agent approved for kidney cancer patients which has Assignment. Retrieved from https://studentshare.org/health-sciences-medicine/1579562-sunitinib-is-an-agent-approved-for-kidney-cancer-patients-which-has-been-shown-to-extend-life-by-46-months-at-an-annual-cost-of-54000-discuss-as-a-healthcare-decision-maker-ie-payer-when-you-would-approve-prescribing-this-drug-on-economic-as-di
Sunitinib Is an Agent Approved for Kidney Cancer Patients Which Has Assignment. https://studentshare.org/health-sciences-medicine/1579562-sunitinib-is-an-agent-approved-for-kidney-cancer-patients-which-has-been-shown-to-extend-life-by-46-months-at-an-annual-cost-of-54000-discuss-as-a-healthcare-decision-maker-ie-payer-when-you-would-approve-prescribing-this-drug-on-economic-as-di.